Effects of benzoctamine (30803-Ba, TACITIN), a new psychoactive drug, on catecholamine metabolism.
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D001692:Biological Transport; D001921:Brain / Q000378:metabolism; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D002396:Catechols / Q000096:biosynthesis; D002417:Cattle; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism; D004781:Environmental Exposure; D004837:Epinephrine / Q000096:biosynthesis; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D008780:Methyltransferases; D008995:Monoamine Oxidase; D009206:Myocardium / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism; D010648:Phenylacetates / Q000096:biosynthesis; D051381:Rats; D012469:Salivary Glands / Q000378:metabolism; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D013696:Temperature; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014316:Tritium; D014443:Tyrosine / Q000097:blood / Q000378:metabolism; D014649:Vas Deferens / Q000378:metabolism
D000873:Anthracenes; D001952:Bridged-Ring Compounds; D002395:Catecholamines; D002396:Catechols; D008744:Methylamines; D010648:Phenylacetates; D014149:Tranquilizing Agents; D014316:Tritium; D014443:Tyrosine; D008995:Monoamine Oxidase; D008780:Methyltransferases; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine